Navigation Links
Adoption of PCI in AMI Patients to Drive Drug-Eluting Stent Use
Date:2/18/2009

Nearly 150,000 PCIs Were Performed on AMI Patients in 2008, According to Millennium Research Group

WALTHAM, Mass., Feb. 18 /PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Interventional Cardiology Devices 2009 report, the use of drug-eluting stents will continue to climb steadily through 2013, driven in large part by the adoption of primary percutaneous coronary intervention (PCI) in Acute Myocardial Infarction (AMI) patients, who accounted for nearly 150,000 PCIs in the US in 2008.

In the past, primary PCI--defined as a PCI performed within 24 hours of the onset of symptoms--was mostly limited to facilities that had surgical back-up present. Studies have shown, however, that AMI patients who undergo primary PCI have improved outcomes over thrombolytics, even without surgical back-up. Experts are now trying to reduce the time it takes to get patients to a cath lab -- in some cases bypassing the emergency room -- which will drive primary PCI adoption and support DES use in AMI patients.

Furthermore, a number of clinical trials in 2007 and 2008 released positive clinical data, which showed that ST-elevation myocardial infarction (STEMI) patients who receive aspiration with stenting have better blood flow, enhanced myocardial function, and lower mortality rates than patients who received angioplasty with stenting or direct stenting.

"The TAPAS trial indicated that STEMI patients treated with aspiration prior to stenting had over 30% lower mortality in the following year compared to those who had angioplasty-with-stent procedures," says Stephanie LaBelle, Senior Analyst at MRG. "As a result, the portion of primary PCIs using aspiration rather than predilation prior to stenting will grow in AMI patients through 2013."

MRG's US Markets for Interventional Cardiology Devices 2009 report provides coverage of key industry trends, inc
'/>"/>

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
2. Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival
3. American Heart Association EMS Survey Uncovers Deficiencies in Response, Treatment and Transfer of Patients With Most Deadly Heart Attacks
4. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
5. Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial
6. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
7. CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year
8. Merck Seronos Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinsons Disease in a Phase III Pivotal Trial
9. First U.S. Patients Enrolled in the REALISM Continued Access Study
10. Nanoemulsion Kills Highly Resistant Bacteria Found in Patients With Cystic Fibrosis
11. Study of Cannabinoid Medicine for Pain Found Patients Got High, but Effects Not Related to Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... ALBANY, New York , July 25, 2014 /PRNewswire/ ... published by Transparency Market Research "Global and China Insulin ... Insulin) - Industry Analysis, Size, Share, Growth, Trends and ... insulin market was valued at USD 19.99 billion in ... of 6.1% from 2013 to 2019 to reach USD ...
(Date:7/25/2014)... July 25, 2014  IDEXX Laboratories, Inc. (NASDAQ: ... second quarter of 2014 increased 11% versus the prior ... for the second quarter of 2014 versus the ... changes in distributor inventory 2 . Earnings per diluted ... increased 11% from the prior year period to $1.10."In ...
(Date:7/25/2014)... Leading events organizer UBM Live announces ... seventh year to São Paulo, Brazil ... The event will co-locate with Food Ingredients South America (FiSA), ... point for the pharmaceutical industry.      (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a) ... sales are now exploring the South America ...
Breaking Medicine Technology:Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29IDEXX Laboratories Announces Second Quarter Results 30IDEXX Laboratories Announces Second Quarter Results 31IDEXX Laboratories Announces Second Quarter Results 32IDEXX Laboratories Announces Second Quarter Results 33
(Date:7/25/2014)... 25, 2014 As thousands of transvaginal ... courts, Bernstein Liebhard LLP notes that the Food & ... consumer advocacy group, Public Citizen, to order a global ... dated May 1, 2014, and released to the public ... for a ban on the marketing of all surgical ...
(Date:7/25/2014)... 2014 (HealthDay News) -- Babies seem to learn even ... the time women are 34 weeks pregnant, their unborn ... voice reciting a familiar nursery rhyme, the researchers report. ... sensory stimulation in the developing fetus," Charlene Krueger, nursing ... College of Nursing, said in a university news release. ...
(Date:7/25/2014)... vulnerable neurons and reduce motor deficits in a ... University School of Medicine have shown. , The ... Parkinson,s Disease . , The findings demonstrate that ... at sufficient levels and have beneficial effects when ... Previous studies of XPro1595 in animals tested more ...
(Date:7/25/2014)... American Society of Anesthesiologists (ASA) today announced the ... Learning Collaborative, a national initiative designed to improve ... More than 40 leading health care organizations ... collaborative, which will convene for the first time ... 25-26, in Schaumburg, Ill. , The PSH collaborative ...
(Date:7/25/2014)... 2014 Parkulture is proud ... and parkour instructor, Jared “JJ” Woods, will be competing ... American Ninja Warrior. The show will premiere on local ... will rerun on the new Esquire Network on Tuesday, ... resident, has been balancing careers as a professional stuntman ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 4Health News:Rhymes Reveal Evidence of Learning in the Womb 2Health News:Anti-inflammatory drug can prevent neuron loss in Parkinson's model 2Health News:ASA launches national Perioperative Surgical Home learning collaborative 2Health News:ASA launches national Perioperative Surgical Home learning collaborative 3Health News:Jared “JJ” Woods Prepares for American Ninja Warrior City Finals 2Health News:Jared “JJ” Woods Prepares for American Ninja Warrior City Finals 3
... Td-Vac priced at Rs. 7.50 has been launched by Serum ... aimed at combating the fatal tetanus and diphtheria (Td) in ... existing dual antigen vaccine used in children and would be ... administered following injury. ,The vaccine is regarded to ...
... which costs US$ 2,300 is used for heart diseases, and ... likely to result // in allergic reactions, the risks ... ,The Northwestern Memorial Hospital’s Dr. Charles Davidson has ... limited. The new drug-eluting stents are Cypher and Taxus. There ...
... been devised that can predict the potential attack of asthma.// ... help to asthmatics control their symptoms more effectively and improve the ... of an asthma attack occurring over the next month was made ... the model is the chaos model. The model the international team ...
... measure of how fast a person can exhale can now ... before a month using a mathematical tool. //It is believed ... patients and lead to the development of better treatment strategies. ... (currently applied to complex systems such as weather) has been ...
... Government promised in June last year that every patient referral ... 'choose and book' system by the end // of this ... the latest month for which figures are available - barely ... ,The Department of Health figures show that between October 2004 ...
... leading vaccine manufacturer Serum Institute of India has manufactured for ... // . ,The vaccine is called Td-Vac and ... and adults. The new vaccine will replace the existing TT ... ,Td-Vac is priced at Rs 7.50 whereas the TT vaccine ...
Cached Medicine News:Health News:Mathematical Model Can Now Help Predict Asthma Risk 2Health News:GP's online referral scheme in UK 'a national IT disaster' 2
... Ordering/Dispensing has gained recognition as the industry ... system. It enables opticians to place instant ... electronic communications technology. When used in conjunction ... frame tracers, lens shapes are automatically transmitted ...
... complete practice and business management software ... and ophthalmologists- It is designed for ... graphically rich and intuitive windows interface ... features and functionality- The multi-user version ...
The K-4500 automated hematology analyzer offers fast reliable test results of 18-parameter plus 3-histograms, valuable for effective diagnosis....
The XT-2000i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...
Medicine Products: